hallucinogen

Luke, Neiloufar, Hendricks, Peter, Williams, Luke, Luke, David ORCID: 0000-0003-2141-2453 , Krediet, Erwin, Maillet, Emeline and Raz, Shlomi (2021) Safety, tolerability, pharmacokinetics, and subjective effects of 50, 75, and 100 μg LSD in healthy participants within a novel intervention paradigm: A proof-of-concept study. Journal of Psychopharmacology, 36 (3). pp. 321-326. ISSN 0269-8811 (Print), 1461-7285 (Online) (doi:https://doi.org/10.1177/02698811211069103)

implementation science

Hendricks, Peter, Copes, Heith, Family, Neiloufar, Williams, Luke, Luke, David ORCID: 0000-0003-2141-2453 and Raz, Shlomi (2022) Perceptions of safety, subjective effects, and beliefs about the clinical utility of lysergic acid diethylamide (LSD) in healthy participants within a novel intervention paradigm: Qualitative results from a proof-of-concept study. Journal of Psychopharmacology, 36 (3). pp. 337-347. ISSN 0269-8811 (Print), 1461-7285 (Online) (doi:https://doi.org/10.1177/02698811211055855)

Luke, Neiloufar, Hendricks, Peter, Williams, Luke, Luke, David ORCID: 0000-0003-2141-2453 , Krediet, Erwin, Maillet, Emeline and Raz, Shlomi (2021) Safety, tolerability, pharmacokinetics, and subjective effects of 50, 75, and 100 μg LSD in healthy participants within a novel intervention paradigm: A proof-of-concept study. Journal of Psychopharmacology, 36 (3). pp. 321-326. ISSN 0269-8811 (Print), 1461-7285 (Online) (doi:https://doi.org/10.1177/02698811211069103)

LSD

Hendricks, Peter, Copes, Heith, Family, Neiloufar, Williams, Luke, Luke, David ORCID: 0000-0003-2141-2453 and Raz, Shlomi (2022) Perceptions of safety, subjective effects, and beliefs about the clinical utility of lysergic acid diethylamide (LSD) in healthy participants within a novel intervention paradigm: Qualitative results from a proof-of-concept study. Journal of Psychopharmacology, 36 (3). pp. 337-347. ISSN 0269-8811 (Print), 1461-7285 (Online) (doi:https://doi.org/10.1177/02698811211055855)

Luke, Neiloufar, Hendricks, Peter, Williams, Luke, Luke, David ORCID: 0000-0003-2141-2453 , Krediet, Erwin, Maillet, Emeline and Raz, Shlomi (2021) Safety, tolerability, pharmacokinetics, and subjective effects of 50, 75, and 100 μg LSD in healthy participants within a novel intervention paradigm: A proof-of-concept study. Journal of Psychopharmacology, 36 (3). pp. 321-326. ISSN 0269-8811 (Print), 1461-7285 (Online) (doi:https://doi.org/10.1177/02698811211069103)

lysergic acid diethylamide

Luke, Neiloufar, Hendricks, Peter, Williams, Luke, Luke, David ORCID: 0000-0003-2141-2453 , Krediet, Erwin, Maillet, Emeline and Raz, Shlomi (2021) Safety, tolerability, pharmacokinetics, and subjective effects of 50, 75, and 100 μg LSD in healthy participants within a novel intervention paradigm: A proof-of-concept study. Journal of Psychopharmacology, 36 (3). pp. 321-326. ISSN 0269-8811 (Print), 1461-7285 (Online) (doi:https://doi.org/10.1177/02698811211069103)

psychedelic

Luke, Neiloufar, Hendricks, Peter, Williams, Luke, Luke, David ORCID: 0000-0003-2141-2453 , Krediet, Erwin, Maillet, Emeline and Raz, Shlomi (2021) Safety, tolerability, pharmacokinetics, and subjective effects of 50, 75, and 100 μg LSD in healthy participants within a novel intervention paradigm: A proof-of-concept study. Journal of Psychopharmacology, 36 (3). pp. 321-326. ISSN 0269-8811 (Print), 1461-7285 (Online) (doi:https://doi.org/10.1177/02698811211069103)

psychedelics

Hendricks, Peter, Copes, Heith, Family, Neiloufar, Williams, Luke, Luke, David ORCID: 0000-0003-2141-2453 and Raz, Shlomi (2022) Perceptions of safety, subjective effects, and beliefs about the clinical utility of lysergic acid diethylamide (LSD) in healthy participants within a novel intervention paradigm: Qualitative results from a proof-of-concept study. Journal of Psychopharmacology, 36 (3). pp. 337-347. ISSN 0269-8811 (Print), 1461-7285 (Online) (doi:https://doi.org/10.1177/02698811211055855)

psychotherapy

Hendricks, Peter, Copes, Heith, Family, Neiloufar, Williams, Luke, Luke, David ORCID: 0000-0003-2141-2453 and Raz, Shlomi (2022) Perceptions of safety, subjective effects, and beliefs about the clinical utility of lysergic acid diethylamide (LSD) in healthy participants within a novel intervention paradigm: Qualitative results from a proof-of-concept study. Journal of Psychopharmacology, 36 (3). pp. 337-347. ISSN 0269-8811 (Print), 1461-7285 (Online) (doi:https://doi.org/10.1177/02698811211055855)

qualitative research

Hendricks, Peter, Copes, Heith, Family, Neiloufar, Williams, Luke, Luke, David ORCID: 0000-0003-2141-2453 and Raz, Shlomi (2022) Perceptions of safety, subjective effects, and beliefs about the clinical utility of lysergic acid diethylamide (LSD) in healthy participants within a novel intervention paradigm: Qualitative results from a proof-of-concept study. Journal of Psychopharmacology, 36 (3). pp. 337-347. ISSN 0269-8811 (Print), 1461-7285 (Online) (doi:https://doi.org/10.1177/02698811211055855)

thematic analysis

Hendricks, Peter, Copes, Heith, Family, Neiloufar, Williams, Luke, Luke, David ORCID: 0000-0003-2141-2453 and Raz, Shlomi (2022) Perceptions of safety, subjective effects, and beliefs about the clinical utility of lysergic acid diethylamide (LSD) in healthy participants within a novel intervention paradigm: Qualitative results from a proof-of-concept study. Journal of Psychopharmacology, 36 (3). pp. 337-347. ISSN 0269-8811 (Print), 1461-7285 (Online) (doi:https://doi.org/10.1177/02698811211055855)